Andrei Kindzelski

Program Director
National Institutes of Health
Bethesda, Maryland, United States

Presentation(s):

• LB 01.5 - Effect of the P-selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial

  Sunday, June 25, 2023
  11:45 – 12:00 ET